Detalhe da pesquisa
1.
Klf10 Gene, a Secondary Modifier and a Pharmacogenomic Biomarker of Hydroxyurea Treatment Among Patients With Hemoglobinopathies.
J Pediatr Hematol Oncol
; 39(3): e155-e162, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28085748
2.
Survival analysis after diagnosis with malignancy of Egyptian adolescent patients: a single-center experience.
J Pediatr Hematol Oncol
; 36(6): e346-52, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24517961
3.
Von Willebrand Factor and Factor VIII levels in Egyptian children with newly diagnosed acute lymphoblastic leukemia in relation to peripheral blast cells and steroid therapy.
J Pediatr Hematol Oncol
; 36(7): 518-23, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25105915
4.
Bone mass and biochemical markers of bone turnover in children and adolescents with chronic immune thrombocytopenia: relation to corticosteroid therapy and vitamin D receptor gene polymorphisms.
Platelets
; 24(4): 282-7, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-22671537
5.
Morbidities and mortality in transfusion-dependent Beta-thalassemia patients (single-center experience).
Pediatr Hematol Oncol
; 30(2): 93-103, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23301991
6.
Romiplostim therapy in children with unresponsive chronic immune thrombocytopenia.
Platelets
; 23(4): 264-73, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22471399